Latest Regulatory Changes News

Smart Parking Limited has delivered record FY25 results, driven by strong organic growth and strategic acquisitions including its entry into the US market with Peak Parking. The company is targeting 3,000 ANPR sites globally by 2028, leveraging proprietary AI technology and a capital-light model.

Navigator Global Investments (NGI) reveals a robust business model focused on minority stakes in alternative asset managers, supported by strategic partnerships and a diversified portfolio. The company targets doubling its EBITDA by 2030 amid strong industry tailwinds.

The FDA's removal of the black box warning on hormone replacement therapies marks a pivotal shift for Mayne Pharma, potentially unlocking new market opportunities and reshaping women’s health treatment.

REA Group reported a solid start to FY26 with 4% revenue growth and a key acquisition that enhances its AI-driven property technology portfolio. Despite challenges in India, the Australian market’s strong yield growth and product adoption underpin a confident outlook.

Light & Wonder, Inc. reported a 3% revenue increase for Q3 2025, driven by its Gaming and iGaming segments, alongside completing the Grover acquisition and refinancing debt with $1 billion in senior notes.

RAS Technology Holdings has landed a significant contract to provide racing data and managed trading services for LeoVegas Group’s UK brands, including BetMGM UK, marking a strategic expansion into regulated markets.

Challenger Limited has provided a detailed update on APRA’s proposed capital standards, highlighting enhanced capital strength and strategic growth opportunities in the life insurance sector.

G8 Education has revised down its full-year earnings forecast due to ongoing occupancy challenges and increased regulatory investments, signaling continued sector pressures.

Westpac Banking Corporation reported a solid $6.9 billion net profit for FY25, underpinned by strong deposit growth and ongoing digital transformation, while advancing ambitious sustainability targets.

Locate Technologies has dispatched its Scheme Booklet to shareholders, outlining the proposed acquisition by Locate NZ and urging a vote in favour at the upcoming virtual meeting.

Avecho Biotechnology advances its pivotal Phase III CBD insomnia trial with 160 patients dosed and secures $2.5 million to accelerate manufacturing and regulatory efforts ahead of a 2026 interim analysis.

Aeris Resources has announced a significant $90 million equity raise through a placement and share purchase plan, aiming to strengthen its balance sheet and fund key growth projects. The raise comes with a discount to recent share prices and supports the company’s strategic expansion and operational improvements.